Comparison of cholinesterase inhibitor safety in real‐world practice
Abstract Introduction Cholinesterase inhibitors (ChEIs) are widely used to treat mild to moderate Alzheimer's disease and related dementia. Clinical trials have focused on placebo comparisons, inadequately addressing within‐class comparative safety. Methods New users of ChEIs in British Columbi...
Saved in:
| Main Authors: | Greg Carney, Ken Bassett, James M. Wright, Malcolm Maclure, Nicolette McGuire, Colin R. Dormuth |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2019-01-01
|
| Series: | Alzheimer’s & Dementia: Translational Research & Clinical Interventions |
| Subjects: | |
| Online Access: | https://doi.org/10.1016/j.trci.2019.09.011 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Trends and disparities in the use of cholinesterase inhibitors to treat Alzheimer’s disease dispensed by the Brazilian public health system – 2008 to 2014: a nation-wide analysis
by: Flávia Silva de Moraes, et al. -
Risk of Antipsychotic Initiation Among Older Dementia Patients Initiating Cholinesterase Inhibitors
by: Chikermane SG, et al.
Published: (2025-03-01) -
Design and synthesis of novel tetrahydronephthalene-1-amine based analogues as cholinesterase inhibitors
by: Warda Parveen, et al.
Published: (2024-10-01) -
Survival analysis of Kasturi tobacco plants in Jember district using the stratified cox and extended cox models.
by: Angga Iryanto Pratama, et al.
Published: (2025-06-01) -
Cholinesterase Inhibitors from Plants and Their Potential in Alzheimer’s Treatment: Systematic Review
by: Maryam N. ALNasser, et al.
Published: (2025-02-01)